Bitte warten ...

CARMAN - GLA 2022-11

Leiter: Herr Univ. Prof. Dr. med. Georg Heß


Herr Univ. Prof. Dr. med. Georg Heß

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

E-Mail senden

Informationen zur Studie


in Aktivierung

Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)

Zusätzliche Dokumente

    Beteiligte Arbeitsgruppen

    Mantelzell- Lymphom (MCL)